O-1125: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Overview == | |||
[[File:O-1125.svg|thumb|right|Chemical structure of O-1125]] | |||
O-1125 | |||
'''O-1125''' is a synthetic compound that acts as a [[cannabinoid receptor]] agonist. It is primarily used in scientific research to study the effects of cannabinoids on the human body. O-1125 is known for its high affinity for the [[CB1 receptor]], which is predominantly found in the [[central nervous system]]. | |||
O-1125 acts as | |||
== | == Chemical Properties == | ||
== | O-1125 is a complex organic molecule with a specific arrangement of atoms that allows it to interact with cannabinoid receptors. The chemical structure of O-1125 includes a core structure that is similar to other cannabinoids, with variations that give it unique properties. | ||
== Mechanism of Action == | |||
O-1125 functions by binding to the CB1 receptor, mimicking the action of naturally occurring [[endocannabinoids]]. This binding leads to a series of intracellular events that modulate neurotransmitter release, affecting various physiological processes such as pain sensation, mood, and appetite. | |||
== Research Applications == | |||
O-1125 is used in research to explore the potential therapeutic effects of cannabinoids. Studies have investigated its role in pain management, neuroprotection, and the modulation of [[immune system]] responses. Researchers also use O-1125 to better understand the [[endocannabinoid system]] and its implications in various diseases. | |||
== Safety and Toxicology == | |||
As with many research chemicals, the safety profile of O-1125 is not fully established. It is important for researchers to handle this compound with care, following appropriate safety protocols to minimize exposure and potential risks. | |||
== Related Pages == | |||
* [[Cannabinoid receptor]] | * [[Cannabinoid receptor]] | ||
* [[Endocannabinoid system]] | * [[Endocannabinoid system]] | ||
* [[ | * [[CB1 receptor]] | ||
* [[Synthetic cannabinoids]] | |||
[[Category:Cannabinoids]] | [[Category:Cannabinoids]] | ||
[[Category: | [[Category:Research chemicals]] | ||
Latest revision as of 03:45, 13 February 2025
Overview[edit]
O-1125 is a synthetic compound that acts as a cannabinoid receptor agonist. It is primarily used in scientific research to study the effects of cannabinoids on the human body. O-1125 is known for its high affinity for the CB1 receptor, which is predominantly found in the central nervous system.
Chemical Properties[edit]
O-1125 is a complex organic molecule with a specific arrangement of atoms that allows it to interact with cannabinoid receptors. The chemical structure of O-1125 includes a core structure that is similar to other cannabinoids, with variations that give it unique properties.
Mechanism of Action[edit]
O-1125 functions by binding to the CB1 receptor, mimicking the action of naturally occurring endocannabinoids. This binding leads to a series of intracellular events that modulate neurotransmitter release, affecting various physiological processes such as pain sensation, mood, and appetite.
Research Applications[edit]
O-1125 is used in research to explore the potential therapeutic effects of cannabinoids. Studies have investigated its role in pain management, neuroprotection, and the modulation of immune system responses. Researchers also use O-1125 to better understand the endocannabinoid system and its implications in various diseases.
Safety and Toxicology[edit]
As with many research chemicals, the safety profile of O-1125 is not fully established. It is important for researchers to handle this compound with care, following appropriate safety protocols to minimize exposure and potential risks.
